Click for best price
Anthracyclines Market Size, Share 2024
The global Anthracyclines market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Oral Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Anthracyclines include AstraZeneca, Sun Pharmaceutical Industries Ltd, Merck & Co., Inc, Lilly, Amgen Inc, GSK plc, Johnson & Johnson Services, Inc, Pfizer Inc and Meiji Holdings Co., Ltd, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Anthracycline is a type of antibiotic that is extracted from numerous types of Streptomyces bacteria. They are used for the treatment of various types of cancer. It damages the DNA of cancer cells and stop its function. This can be done either by intercalating into the base pairs in the DNA minor grooves or by causing free radical damage of the ribose in the DNA. Daunorubicin, doxorubicin, and epirubicin are some of the top examples of anthracyclines.
This report aims to provide a comprehensive presentation of the global market for Anthracyclines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anthracyclines. This report contains market size and forecasts of Anthracyclines in global, including the following market information:
Global Anthracyclines Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Anthracyclines Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Anthracyclines companies in 2023 (%)
We surveyed the Anthracyclines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anthracyclines Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Anthracyclines Market Segment Percentages, by Type, 2023 (%)
Oral
Parenteral
Global Anthracyclines Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Anthracyclines Market Segment Percentages, by Application, 2023 (%)
Leukemia
Hodgkin Lymphoma
Bladder Cancer
Breast Cancer
Other
Global Anthracyclines Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Anthracyclines Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anthracyclines revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Anthracyclines revenues share in global market, 2023 (%)
Key companies Anthracyclines sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Anthracyclines sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Sun Pharmaceutical Industries Ltd
Merck & Co., Inc
Lilly
Amgen Inc
GSK plc
Johnson & Johnson Services, Inc
Pfizer Inc
Meiji Holdings Co., Ltd
MicroBiopharm Japan Co., Ltd
Synbias Pharma
Hikma Pharmaceuticals PLC
Cumberland Pharmaceuticals Inc
Cadila Pharmaceuticals
Cipla Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anthracyclines, market overview.
Chapter 2: Global Anthracyclines market size in revenue and volume.
Chapter 3: Detailed analysis of Anthracyclines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anthracyclines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anthracyclines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
Report Attributes |
Report Details |
Report Title |
Anthracyclines Market, Global Outlook and Forecast 2024-2030 |
Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
Base Year |
2023 |
Forecast Year |
2031 |
Number of Pages |
111 Pages |
Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anthracyclines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anthracyclines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anthracyclines Overall Market Size
2.1 Global Anthracyclines Market Size: 2023 VS 2030
2.2 Global Anthracyclines Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Anthracyclines Sales: 2019-2030
3 Company Landscape
3.1 Top Anthracyclines Players in Global Market
3.2 Top Global Anthracyclines Companies Ranked by Revenue
3.3 Global Anthracyclines Revenue by Companies
3.4 Global Anthracyclines Sales by Companies
3.5 Global Anthracyclines Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Anthracyclines Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Anthracyclines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anthracyclines Players in Global Market
3.8.1 List of Global Tier 1 Anthracyclines Companies
3.8.2 List of Global Tier 2 and Tier 3 Anthracyclines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anthracyclines Market Size Markets, 2023 & 2030
4.1.2 Oral
4.1.3 Parenteral
4.2 By Type - Global Anthracyclines Revenue & Forecasts
4.2.1 By Type - Global Anthracyclines Revenue, 2019-2024
4.2.2 By Type - Global Anthracyclines Revenue, 2025-2030
4.2.3 By Type - Global Anthracyclines Revenue Market Share, 2019-2030
4.3 By Type - Global Anthracyclines Sales & Forecasts
4.3.1 By Type - Global Anthracyclines Sales, 2019-2024
4.3.2 By Type - Global Anthracyclines Sales, 2025-2030
4.3.3 By Type - Global Anthracyclines Sales Market Share, 2019-2030
4.4 By Type - Global Anthracyclines Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anthracyclines Market Size, 2023 & 2030
5.1.2 Leukemia
5.1.3 Hodgkin Lymphoma
5.1.4 Bladder Cancer
5.1.5 Breast Cancer
5.1.6 Other
5.2 By Application - Global Anthracyclines Revenue & Forecasts
5.2.1 By Application - Global Anthracyclines Revenue, 2019-2024
5.2.2 By Application - Global Anthracyclines Revenue, 2025-2030
5.2.3 By Application - Global Anthracyclines Revenue Market Share, 2019-2030
5.3 By Application - Global Anthracyclines Sales & Forecasts
5.3.1 By Application - Global Anthracyclines Sales, 2019-2024
5.3.2 By Application - Global Anthracyclines Sales, 2025-2030
5.3.3 By Application - Global Anthracyclines Sales Market Share, 2019-2030
5.4 By Application - Global Anthracyclines Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Anthracyclines Market Size, 2023 & 2030
6.2 By Region - Global Anthracyclines Revenue & Forecasts
6.2.1 By Region - Global Anthracyclines Revenue, 2019-2024
6.2.2 By Region - Global Anthracyclines Revenue, 2025-2030
6.2.3 By Region - Global Anthracyclines Revenue Market Share, 2019-2030
6.3 By Region - Global Anthracyclines Sales & Forecasts
6.3.1 By Region - Global Anthracyclines Sales, 2019-2024
6.3.2 By Region - Global Anthracyclines Sales, 2025-2030
6.3.3 By Region - Global Anthracyclines Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Anthracyclines Revenue, 2019-2030
6.4.2 By Country - North America Anthracyclines Sales, 2019-2030
6.4.3 US Anthracyclines Market Size, 2019-2030
6.4.4 Canada Anthracyclines Market Size, 2019-2030
6.4.5 Mexico Anthracyclines Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Anthracyclines Revenue, 2019-2030
6.5.2 By Country - Europe Anthracyclines Sales, 2019-2030
6.5.3 Germany Anthracyclines Market Size, 2019-2030
6.5.4 France Anthracyclines Market Size, 2019-2030
6.5.5 U.K. Anthracyclines Market Size, 2019-2030
6.5.6 Italy Anthracyclines Market Size, 2019-2030
6.5.7 Russia Anthracyclines Market Size, 2019-2030
6.5.8 Nordic Countries Anthracyclines Market Size, 2019-2030
6.5.9 Benelux Anthracyclines Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Anthracyclines Revenue, 2019-2030
6.6.2 By Region - Asia Anthracyclines Sales, 2019-2030
6.6.3 China Anthracyclines Market Size, 2019-2030
6.6.4 Japan Anthracyclines Market Size, 2019-2030
6.6.5 South Korea Anthracyclines Market Size, 2019-2030
6.6.6 Southeast Asia Anthracyclines Market Size, 2019-2030
6.6.7 India Anthracyclines Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Anthracyclines Revenue, 2019-2030
6.7.2 By Country - South America Anthracyclines Sales, 2019-2030
6.7.3 Brazil Anthracyclines Market Size, 2019-2030
6.7.4 Argentina Anthracyclines Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anthracyclines Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Anthracyclines Sales, 2019-2030
6.8.3 Turkey Anthracyclines Market Size, 2019-2030
6.8.4 Israel Anthracyclines Market Size, 2019-2030
6.8.5 Saudi Arabia Anthracyclines Market Size, 2019-2030
6.8.6 UAE Anthracyclines Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Anthracyclines Major Product Offerings
7.1.4 AstraZeneca Anthracyclines Sales and Revenue in Global (2019-2024)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Sun Pharmaceutical Industries Ltd
7.2.1 Sun Pharmaceutical Industries Ltd Company Summary
7.2.2 Sun Pharmaceutical Industries Ltd Business Overview
7.2.3 Sun Pharmaceutical Industries Ltd Anthracyclines Major Product Offerings
7.2.4 Sun Pharmaceutical Industries Ltd Anthracyclines Sales and Revenue in Global (2019-2024)
7.2.5 Sun Pharmaceutical Industries Ltd Key News & Latest Developments
7.3 Merck & Co., Inc
7.3.1 Merck & Co., Inc Company Summary
7.3.2 Merck & Co., Inc Business Overview
7.3.3 Merck & Co., Inc Anthracyclines Major Product Offerings
7.3.4 Merck & Co., Inc Anthracyclines Sales and Revenue in Global (2019-2024)
7.3.5 Merck & Co., Inc Key News & Latest Developments
7.4 Lilly
7.4.1 Lilly Company Summary
7.4.2 Lilly Business Overview
7.4.3 Lilly Anthracyclines Major Product Offerings
7.4.4 Lilly Anthracyclines Sales and Revenue in Global (2019-2024)
7.4.5 Lilly Key News & Latest Developments
7.5 Amgen Inc
7.5.1 Amgen Inc Company Summary
7.5.2 Amgen Inc Business Overview
7.5.3 Amgen Inc Anthracyclines Major Product Offerings
7.5.4 Amgen Inc Anthracyclines Sales and Revenue in Global (2019-2024)
7.5.5 Amgen Inc Key News & Latest Developments
7.6 GSK plc
7.6.1 GSK plc Company Summary
7.6.2 GSK plc Business Overview
7.6.3 GSK plc Anthracyclines Major Product Offerings
7.6.4 GSK plc Anthracyclines Sales and Revenue in Global (2019-2024)
7.6.5 GSK plc Key News & Latest Developments
7.7 Johnson & Johnson Services, Inc
7.7.1 Johnson & Johnson Services, Inc Company Summary
7.7.2 Johnson & Johnson Services, Inc Business Overview
7.7.3 Johnson & Johnson Services, Inc Anthracyclines Major Product Offerings
7.7.4 Johnson & Johnson Services, Inc Anthracyclines Sales and Revenue in Global (2019-2024)
7.7.5 Johnson & Johnson Services, Inc Key News & Latest Developments
7.8 Pfizer Inc
7.8.1 Pfizer Inc Company Summary
7.8.2 Pfizer Inc Business Overview
7.8.3 Pfizer Inc Anthracyclines Major Product Offerings
7.8.4 Pfizer Inc Anthracyclines Sales and Revenue in Global (2019-2024)
7.8.5 Pfizer Inc Key News & Latest Developments
7.9 Meiji Holdings Co., Ltd
7.9.1 Meiji Holdings Co., Ltd Company Summary
7.9.2 Meiji Holdings Co., Ltd Business Overview
7.9.3 Meiji Holdings Co., Ltd Anthracyclines Major Product Offerings
7.9.4 Meiji Holdings Co., Ltd Anthracyclines Sales and Revenue in Global (2019-2024)
7.9.5 Meiji Holdings Co., Ltd Key News & Latest Developments
7.10 MicroBiopharm Japan Co., Ltd
7.10.1 MicroBiopharm Japan Co., Ltd Company Summary
7.10.2 MicroBiopharm Japan Co., Ltd Business Overview
7.10.3 MicroBiopharm Japan Co., Ltd Anthracyclines Major Product Offerings
7.10.4 MicroBiopharm Japan Co., Ltd Anthracyclines Sales and Revenue in Global (2019-2024)
7.10.5 MicroBiopharm Japan Co., Ltd Key News & Latest Developments
7.11 Synbias Pharma
7.11.1 Synbias Pharma Company Summary
7.11.2 Synbias Pharma Anthracyclines Business Overview
7.11.3 Synbias Pharma Anthracyclines Major Product Offerings
7.11.4 Synbias Pharma Anthracyclines Sales and Revenue in Global (2019-2024)
7.11.5 Synbias Pharma Key News & Latest Developments
7.12 Hikma Pharmaceuticals PLC
7.12.1 Hikma Pharmaceuticals PLC Company Summary
7.12.2 Hikma Pharmaceuticals PLC Anthracyclines Business Overview
7.12.3 Hikma Pharmaceuticals PLC Anthracyclines Major Product Offerings
7.12.4 Hikma Pharmaceuticals PLC Anthracyclines Sales and Revenue in Global (2019-2024)
7.12.5 Hikma Pharmaceuticals PLC Key News & Latest Developments
7.13 Cumberland Pharmaceuticals Inc
7.13.1 Cumberland Pharmaceuticals Inc Company Summary
7.13.2 Cumberland Pharmaceuticals Inc Anthracyclines Business Overview
7.13.3 Cumberland Pharmaceuticals Inc Anthracyclines Major Product Offerings
7.13.4 Cumberland Pharmaceuticals Inc Anthracyclines Sales and Revenue in Global (2019-2024)
7.13.5 Cumberland Pharmaceuticals Inc Key News & Latest Developments
7.14 Cadila Pharmaceuticals
7.14.1 Cadila Pharmaceuticals Company Summary
7.14.2 Cadila Pharmaceuticals Business Overview
7.14.3 Cadila Pharmaceuticals Anthracyclines Major Product Offerings
7.14.4 Cadila Pharmaceuticals Anthracyclines Sales and Revenue in Global (2019-2024)
7.14.5 Cadila Pharmaceuticals Key News & Latest Developments
7.15 Cipla Inc
7.15.1 Cipla Inc Company Summary
7.15.2 Cipla Inc Business Overview
7.15.3 Cipla Inc Anthracyclines Major Product Offerings
7.15.4 Cipla Inc Anthracyclines Sales and Revenue in Global (2019-2024)
7.15.5 Cipla Inc Key News & Latest Developments
8 Global Anthracyclines Production Capacity, Analysis
8.1 Global Anthracyclines Production Capacity, 2019-2030
8.2 Anthracyclines Production Capacity of Key Manufacturers in Global Market
8.3 Global Anthracyclines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anthracyclines Supply Chain Analysis
10.1 Anthracyclines Industry Value Chain
10.2 Anthracyclines Upstream Market
10.3 Anthracyclines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anthracyclines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Anthracyclines in Global Market
Table 2. Top Anthracyclines Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Anthracyclines Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Anthracyclines Revenue Share by Companies, 2019-2024
Table 5. Global Anthracyclines Sales by Companies, (K Units), 2019-2024
Table 6. Global Anthracyclines Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Anthracyclines Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Anthracyclines Product Type
Table 9. List of Global Tier 1 Anthracyclines Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anthracyclines Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Anthracyclines Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Anthracyclines Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Anthracyclines Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Anthracyclines Sales (K Units), 2019-2024
Table 15. By Type - Global Anthracyclines Sales (K Units), 2025-2030
Table 16. By Application ? Global Anthracyclines Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Anthracyclines Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Anthracyclines Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Anthracyclines Sales (K Units), 2019-2024
Table 20. By Application - Global Anthracyclines Sales (K Units), 2025-2030
Table 21. By Region ? Global Anthracyclines Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Anthracyclines Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Anthracyclines Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Anthracyclines Sales (K Units), 2019-2024
Table 25. By Region - Global Anthracyclines Sales (K Units), 2025-2030
Table 26. By Country - North America Anthracyclines Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Anthracyclines Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Anthracyclines Sales, (K Units), 2019-2024
Table 29. By Country - North America Anthracyclines Sales, (K Units), 2025-2030
Table 30. By Country - Europe Anthracyclines Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Anthracyclines Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Anthracyclines Sales, (K Units), 2019-2024
Table 33. By Country - Europe Anthracyclines Sales, (K Units), 2025-2030
Table 34. By Region - Asia Anthracyclines Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Anthracyclines Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Anthracyclines Sales, (K Units), 2019-2024
Table 37. By Region - Asia Anthracyclines Sales, (K Units), 2025-2030
Table 38. By Country - South America Anthracyclines Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Anthracyclines Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Anthracyclines Sales, (K Units), 2019-2024
Table 41. By Country - South America Anthracyclines Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Anthracyclines Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Anthracyclines Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Anthracyclines Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Anthracyclines Sales, (K Units), 2025-2030
Table 46. AstraZeneca Company Summary
Table 47. AstraZeneca Anthracyclines Product Offerings
Table 48. AstraZeneca Anthracyclines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. AstraZeneca Key News & Latest Developments
Table 50. Sun Pharmaceutical Industries Ltd Company Summary
Table 51. Sun Pharmaceutical Industries Ltd Anthracyclines Product Offerings
Table 52. Sun Pharmaceutical Industries Ltd Anthracyclines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Sun Pharmaceutical Industries Ltd Key News & Latest Developments
Table 54. Merck & Co., Inc Company Summary
Table 55. Merck & Co., Inc Anthracyclines Product Offerings
Table 56. Merck & Co., Inc Anthracyclines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Merck & Co., Inc Key News & Latest Developments
Table 58. Lilly Company Summary
Table 59. Lilly Anthracyclines Product Offerings
Table 60. Lilly Anthracyclines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Lilly Key News & Latest Developments
Table 62. Amgen Inc Company Summary
Table 63. Amgen Inc Anthracyclines Product Offerings
Table 64. Amgen Inc Anthracyclines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Amgen Inc Key News & Latest Developments
Table 66. GSK plc Company Summary
Table 67. GSK plc Anthracyclines Product Offerings
Table 68. GSK plc Anthracyclines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. GSK plc Key News & Latest Developments
Table 70. Johnson & Johnson Services, Inc Company Summary
Table 71. Johnson & Johnson Services, Inc Anthracyclines Product Offerings
Table 72. Johnson & Johnson Services, Inc Anthracyclines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Johnson & Johnson Services, Inc Key News & Latest Developments
Table 74. Pfizer Inc Company Summary
Table 75. Pfizer Inc Anthracyclines Product Offerings
Table 76. Pfizer Inc Anthracyclines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Pfizer Inc Key News & Latest Developments
Table 78. Meiji Holdings Co., Ltd Company Summary
Table 79. Meiji Holdings Co., Ltd Anthracyclines Product Offerings
Table 80. Meiji Holdings Co., Ltd Anthracyclines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Meiji Holdings Co., Ltd Key News & Latest Developments
Table 82. MicroBiopharm Japan Co., Ltd Company Summary
Table 83. MicroBiopharm Japan Co., Ltd Anthracyclines Product Offerings
Table 84. MicroBiopharm Japan Co., Ltd Anthracyclines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. MicroBiopharm Japan Co., Ltd Key News & Latest Developments
Table 86. Synbias Pharma Company Summary
Table 87. Synbias Pharma Anthracyclines Product Offerings
Table 88. Synbias Pharma Anthracyclines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Synbias Pharma Key News & Latest Developments
Table 90. Hikma Pharmaceuticals PLC Company Summary
Table 91. Hikma Pharmaceuticals PLC Anthracyclines Product Offerings
Table 92. Hikma Pharmaceuticals PLC Anthracyclines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Hikma Pharmaceuticals PLC Key News & Latest Developments
Table 94. Cumberland Pharmaceuticals Inc Company Summary
Table 95. Cumberland Pharmaceuticals Inc Anthracyclines Product Offerings
Table 96. Cumberland Pharmaceuticals Inc Anthracyclines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Cumberland Pharmaceuticals Inc Key News & Latest Developments
Table 98. Cadila Pharmaceuticals Company Summary
Table 99. Cadila Pharmaceuticals Anthracyclines Product Offerings
Table 100. Cadila Pharmaceuticals Anthracyclines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. Cadila Pharmaceuticals Key News & Latest Developments
Table 102. Cipla Inc Company Summary
Table 103. Cipla Inc Anthracyclines Product Offerings
Table 104. Cipla Inc Anthracyclines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 105. Cipla Inc Key News & Latest Developments
Table 106. Anthracyclines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 107. Global Anthracyclines Capacity Market Share of Key Manufacturers, 2021-2024
Table 108. Global Anthracyclines Production by Region, 2019-2024 (K Units)
Table 109. Global Anthracyclines Production by Region, 2025-2030 (K Units)
Table 110. Anthracyclines Market Opportunities & Trends in Global Market
Table 111. Anthracyclines Market Drivers in Global Market
Table 112. Anthracyclines Market Restraints in Global Market
Table 113. Anthracyclines Raw Materials
Table 114. Anthracyclines Raw Materials Suppliers in Global Market
Table 115. Typical Anthracyclines Downstream
Table 116. Anthracyclines Downstream Clients in Global Market
Table 117. Anthracyclines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anthracyclines Segment by Type in 2023
Figure 2. Anthracyclines Segment by Application in 2023
Figure 3. Global Anthracyclines Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Anthracyclines Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Anthracyclines Revenue, 2019-2030 (US$, Mn)
Figure 7. Anthracyclines Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anthracyclines Revenue in 2023
Figure 9. By Type - Global Anthracyclines Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Anthracyclines Revenue Market Share, 2019-2030
Figure 11. By Type - Global Anthracyclines Sales Market Share, 2019-2030
Figure 12. By Type - Global Anthracyclines Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Anthracyclines Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Anthracyclines Revenue Market Share, 2019-2030
Figure 15. By Application - Global Anthracyclines Sales Market Share, 2019-2030
Figure 16. By Application - Global Anthracyclines Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Anthracyclines Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Anthracyclines Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Anthracyclines Revenue Market Share, 2019-2030
Figure 20. By Region - Global Anthracyclines Sales Market Share, 2019-2030
Figure 21. By Country - North America Anthracyclines Revenue Market Share, 2019-2030
Figure 22. By Country - North America Anthracyclines Sales Market Share, 2019-2030
Figure 23. US Anthracyclines Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Anthracyclines Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Anthracyclines Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Anthracyclines Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Anthracyclines Sales Market Share, 2019-2030
Figure 28. Germany Anthracyclines Revenue, (US$, Mn), 2019-2030
Figure 29. France Anthracyclines Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Anthracyclines Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Anthracyclines Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Anthracyclines Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Anthracyclines Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Anthracyclines Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Anthracyclines Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Anthracyclines Sales Market Share, 2019-2030
Figure 37. China Anthracyclines Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Anthracyclines Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Anthracyclines Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Anthracyclines Revenue, (US$, Mn), 2019-2030
Figure 41. India Anthracyclines Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Anthracyclines Revenue Market Share, 2019-2030
Figure 43. By Country - South America Anthracyclines Sales Market Share, 2019-2030
Figure 44. Brazil Anthracyclines Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Anthracyclines Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Anthracyclines Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Anthracyclines Sales Market Share, 2019-2030
Figure 48. Turkey Anthracyclines Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Anthracyclines Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Anthracyclines Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Anthracyclines Revenue, (US$, Mn), 2019-2030
Figure 52. Global Anthracyclines Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Anthracyclines by Region, 2023 VS 2030
Figure 54. Anthracyclines Industry Value Chain
Figure 55. Marketing Channels